Human neutrophil peptide-1 (HNP-1): a new anti-leishmanial drug candidate. by Sara Dabirian, Yasaman Taslimi, Farnaz Zahedifard, Elham Gholami, Fatemeh Doustdari, Mahdieh Motamedirad, Shohreh Khatami, Kayhan Azadmanesh, Susanne Nylen, Sima Rafati

Connect to this object online.

Enhanced protective efficacy of nonpathogenic recombinant leishmania tarentolae expressing cysteine proteinases combined with a sand fly salivary antigen. by Farnaz Zahedifard, Elham Gholami, Tahereh Taheri, Yasaman Taslimi, Fatemeh Doustdari, Negar Seyed, Fatemeh Torkashvand, Claudio Meneses, Barbara Papadopoulou, Shaden Kamhawi, Jesus G Valenzuela, Sima Rafati

Connect to this object online.

In silico analysis of six known Leishmania major antigens and in vitro evaluation of specific epitopes eliciting HLA-A2 restricted CD8 T cell response. by Negar Seyed, Farnaz Zahedifard, Shima Safaiyan, Elham Gholami, Fatemeh Doustdari, Kayhan Azadmanesh, Maryam Mirzaei, Nasir Saeedi Eslami, Akbar Khadem Sadegh, Ali Eslami Far, Iraj Sharifi, Sima Rafati

Connect to this object online.

Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasis. by Noushin Saljoughian, Tahereh Taheri, Farnaz Zahedifard, Yasaman Taslimi, Fatemeh Doustdari, Azam Bolhassani, Delaram Doroud, Hiva Azizi, Kazem Heidari, Mohammad Vasei, Nabiollah Namvar Asl, Barbara Papadopoulou, Sima Rafati

Connect to this object online.